                         SEQUENCE LISTING

<110>  Ramot at Tel-Aviv University Ltd.
       Offen, Daniel
       Aharony, Israel
 
<120>  PEPTIDES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

<130>  55956

<150>  US 61/711,309
<151>  2012-10-09

<160>  31    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  1

Ile Val Leu Asp 
1               


<210>  2
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  2

Ile Val Leu Asp Gly Thr Asp Asn 
1               5               


<210>  3
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  3

Ile Val Leu Asp Gly Thr Asp 
1               5           


<210>  4
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  4

Ile Val Leu Asp Gly Thr 
1               5       


<210>  5
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  5

Ile Val Leu Asp Gly 
1               5   


<210>  6
<211>  24
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a peptide which include both the Htt sequence and the 
       cell penetrating peptide

<400>  6

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Ser Ser Glu 
1               5                   10                  15      


Ile Val Leu Asp Gly Thr Asp Asn 
            20                  


<210>  7
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a cell penetrating peptide

<400>  7

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln 
1               5                   10              


<210>  8
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a cell penetrating peptide

<400>  8

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro 
1               5                   10          


<210>  9
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a cell penetrating peptide

<400>  9

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro 
1               5                   10      


<210>  10
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a cell penetrating peptide

<400>  10

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10  


<210>  11
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a cell penetrating peptide

<400>  11

Gly Arg Lys Lys Arg Arg Gln Arg Arg 
1               5                   


<210>  12
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a cell penetrating peptide

<400>  12

Gly Arg Lys Lys Arg Arg Gln Arg 
1               5               


<210>  13
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a cell penetrating peptide

<400>  13

Gly Arg Lys Lys Arg Arg Gln 
1               5           


<210>  14
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a cell penetrating peptide

<400>  14

Tyr Gly Arg Lys Lys Arg Arg 
1               5           


<210>  15
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a cell penetrating peptide

<400>  15

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210>  16
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a cell penetrating peptide

<400>  16

Arg Arg Gln Arg Arg 
1               5   


<210>  17
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a peptide which include both the Htt sequence and the 
       cell penetrating peptide

<400>  17

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Ser Ser Glu 
1               5                   10                  15      


Ile Val Leu Asp Gly Thr Asp 
            20              


<210>  18
<211>  22
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a peptide which include both the Htt sequence and the 
       cell penetrating peptide

<400>  18

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Ser Ser Glu 
1               5                   10                  15      


Ile Val Leu Asp Gly Thr 
            20          


<210>  19
<211>  21
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a peptide which include both the Htt sequence and the 
       cell penetrating peptide

<400>  19

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Ser Ser Glu 
1               5                   10                  15      


Ile Val Leu Asp Gly 
            20      


<210>  20
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a peptide which include both the Htt sequence and the 
       cell penetrating peptide

<400>  20

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Ser Ser Glu 
1               5                   10                  15      


Ile Val Leu Asp 
            20  


<210>  21
<211>  21
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a peptide which include both the Htt sequence and the 
       cell penetrating peptide

<400>  21

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Ile Val Leu 
1               5                   10                  15      


Asp Gly Thr Asp Asn 
            20      


<210>  22
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a peptide which include both the Htt sequence and the 
       cell penetrating peptide

<400>  22

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Ser Ser Glu Ile 
1               5                   10                  15      


Val Leu Asp Gly Thr Asp Asn 
            20              


<210>  23
<211>  22
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a peptide which include both the Htt sequence and the 
       cell penetrating peptide

<400>  23

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Ser Ser Glu Ile Val 
1               5                   10                  15      


Leu Asp Gly Thr Asp Asn 
            20          


<210>  24
<211>  21
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a peptide which include both the Htt sequence and the 
       cell penetrating peptide

<400>  24

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Ser Ser Glu Ile Val Leu 
1               5                   10                  15      


Asp Gly Thr Asp Asn 
            20      


<210>  25
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a peptide which include both the Htt sequence and the 
       cell penetrating peptide

<400>  25

Gly Arg Lys Lys Arg Arg Gln Arg Arg Ser Ser Glu Ile Val Leu Asp 
1               5                   10                  15      


Gly Thr Asp Asn 
            20  


<210>  26
<211>  19
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a peptide which include both the Htt sequence and the 
       cell penetrating peptide

<400>  26

Gly Arg Lys Lys Arg Arg Gln Arg Ser Ser Glu Ile Val Leu Asp Gly 
1               5                   10                  15      


Thr Asp Asn 
            


<210>  27
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Example of a peptide which include both the Htt sequence and the 
       cell penetrating peptide

<400>  27

Gly Arg Lys Lys Arg Arg Gln Ser Ser Glu Ile Val Leu Asp Gly Thr 
1               5                   10                  15      


Asp Asn 
        


<210>  28
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  28

Tyr Gly Arg Lys Lys Arg Arg Ser Ser Glu Ile Val Leu Asp Gly Thr 
1               5                   10                  15      


Asp Asn 
        


<210>  29
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  29

Tyr Gly Arg Lys Lys Arg Arg Ser Ser Glu Ala Val Leu Asp Gly Thr 
1               5                   10                  15      


Asp Asn 
        


<210>  30
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  30

Tyr Gly Arg Lys Lys Arg Arg Ser Ser Glu Ile Val Leu Ala Gly Thr 
1               5                   10                  15      


Asp Asn 
        


<210>  31
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  31

Tyr Gly Arg Lys Lys Arg Arg Ser Ser Glu Ile Val Leu Asp Gly Thr 
1               5                   10                  15      


Ala Asn 
        


